A: Univariate analysis, breast cancer (n = 793) | ||||
---|---|---|---|---|
Factors | Â | Elafin Negative (n = 311) | Elafin Negative (n = 482) | P value |
Age of diagnosis, year | 0.02 | |||
Mean | 55.5 | 53.5 | Â | |
Median (range) | 55 (26–86) | 52 (25–87) |  | |
Stage | Â | Â | <0.0001 | |
I | 120 (38.7) | 115 (24.0) | Â | |
IIA | 128 (41.3) | 241 (50.2) | Â | |
IIB | 62 (20.0) | 124 (25.8) | Â | |
Unknown | 1 | 2 | Â | |
ER | Â | Â | <0.0001 | |
Positive | 266 (85.5) | 280 (58.3) | Â | |
Negative | 45 (14.5) | 200 (41.7) | Â | |
Unknown | 0 | 2 | Â | |
PR | Â | Â | <0.0001 | |
Positive | 218 (70.1) | 236 (49.2) | Â | |
Negative | 93 (29.9) | 244 (50.8) | Â | |
Unknown | 0 | 2 | Â | |
HER-2 | Â | Â | 0.013 | |
Positive | 42 (13.5) | 98 (20.4) | Â | |
Negative | 269 (86.5) | 383 (79.6) | Â | |
Unknown | 0 | 1 | Â | |
Grade | Â | Â | <0.0001 | |
I | 41 (14.2) | 31 (6.8) | Â | |
II | 186 (64.6) | 197 (43.5) | Â | |
III | 61 (21.2) | 225 (49.7) | Â | |
Unknown | 23 | 29 | Â | |
Tumor subtype | Â | Â | <0.0001 | |
Luminal A | 185 (61.9) | 158 (33.1) | Â | |
Luminal B | 45 (15.1) | 94 (19.8) | Â | |
Her2 positive | 42 (14.0) | 98 (20.7) | Â | |
Triple negative | 27 (9.0) | 125 (26.4) | Â | |
Unknown | 12 | 7 | Â | |
Recurrence | Â | Â | <0.0001 | |
No | 250 (80.9) | 298 (62.3) | Â | |
Yes | 59 (19.1) | 180 (37.7) | Â | |
Unknown | 2 | 4 | Â | |
B: Multivariate Cox proportional hazards analysis of clinicopathologic variables’ influence on breast cancer RFS in whole cohort (n = 793) | ||||
Factor | HR | Se | P | 95% CI |
Stage | Â | Â | Â | Â |
I | referent | Â | Â | Â |
IIA | 1.67 | 0.31 | 0.005 | 1.17-2.39 |
IIB | 2.41 | 0.47 | <0.0001 | 1.65-3.52 |
Age | 0.98 | 0.01 | <0.0001 | 0.97-0.99 |
Elafin positive | 1.94 | 0.3 | <0.0001 | 1.44-2.62 |